Table 1.
Demographic characteristics of cohort
| Variable | Total | UTI (N=136) | Non-UTI (N=2824) | P-Value |
|---|---|---|---|---|
| Age (Mean ± SD) | 74.3 ± 6.9 | 73.3 ± 6.5 | 0.13 | |
| Age | ||||
| 65–70 | 1201 (40.6%) | 51 (37.5%) | 1150 (40.7%) | 0.24 |
| 71–75 | 800 (27.0%) | 32 (23.5%) | 768 (27.2%) | |
| 76–80 | 519 (17.5%) | 25 (18.4%) | 494 (17.5%) | |
| 81+ | 440 (14.9%) | 28 (20.6%) | 412 (14.6%) | |
| Gender | ||||
| Male | 2233 (75.4%) | 42 (30.9%) | 2191 (77.6%) | <0.01 |
| Female | 727 (24.6%) | 94 (69.1%) | 633 (22.4%) | |
| Race | ||||
| White | 1926 (65.1%) | 95 (69.9%) | 1831 (64.8%) | 0.40 |
| Non-White | 946 (32.0%) | 40 (29.4%) | 906 (32.1%) | |
| meds (Mean ± SD) | 11.6 ± 5.9 | 9.03 ± 5.3 | <0.01 | |
| Number of Medications | ||||
| 0–5 | 768 (25.9%) | 22 (16.2%) | 746 (26.4%) | <0.01 |
| 6–8 | 723 (24.4%) | 19 (14.0%) | 704 (24.9%) | |
| 9–12 | 781 (26.4%) | 38 (27.9%) | 743 (26.3%) | |
| 13–44 | 688 (23.2%) | 57 (41.9%) | 631 (22.3%) | |
| BMI (Mean ± SD) | 27.2 ± 4.9 | 26.9 ± 4.9 | 0.59 | |
| TUGT (Mean ± SD) | 13.8 ± 10.4 | 10.8 ± 4.5 | <0.01 | |
| TUGT | ||||
| Fast (<= 10 sec) | 1760 (59.5%) | 59 (43.4%) | 1701 (60.2%) | <0.01 |
| Intermediate (11 to 14 sec) | 858 (29.0%) | 40 (29.4%) | 818 (29.0%) | |
| Slow (>= 15 sec) | 342 (11.6%) | 37 (27.2%) | 305 (10.8%) |